GROWTH-FACTORS IN WOUND-HEALING

被引:144
作者
LAWRENCE, WT
DIEGELMANN, RF
机构
[1] Division of Plastic and Reconstructive Surgery, University of North Carolina School of Medicine, Chapel Hill, NC
[2] The Wound Healing Center, Division of Plastic and Reconstructive Surgery, Medical College of Virginia, Richmond, VA
关键词
D O I
10.1016/0738-081X(94)90266-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Normal wound healing requires the coordinated completion of a variety of cellular activities. The cellular activities involved in normal healing include phagocytosis, chemotaxis, mitogenesis, collagen synthesis, and the synthesis of other matrix components. After a wound is created, phagocytosis of bacteria and damaged tissue is a necessary prerequisite to most other healing processes. Neutrophils and macrophages are the primary phagocytic cells. Chemotaxis is the migration of cells against a gradient. Chemotactic agents for inflammatory cells, fibroblasts, and cells involved in angiogenesis contribute to the healing process. Mitogenesis-stimulating agents cause cells required for healing to divide. Mitogenesis generates more fibroblasts, epithelial cells, and angiogenic cells to carry out the healing process. New collagen and ground substance are required to give the healing wound strength and structure, and the synthesis of these proteins and glycoproteins, primarily by fibroblasts, is another critical component of the healing process. Wound contraction and scar remodeling are other major aspects of healing. These processes are most likely not purely cellular activities, though cells are required for wound contraction and scar remodeling to occur. All of these processes must be accomplished for a wound to heal. © 1994.
引用
收藏
页码:157 / 169
页数:13
相关论文
共 154 条
  • [1] Clark, Growth factors and wound repair, J Cell Biochem, 46, pp. 1-2, (1991)
  • [2] Bernfield, Sanderson, Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors, Phil Trans R Soc Lond, 327, pp. 171-186, (1990)
  • [3] Nishiyama, Akutsu, Horii, Et al., Response to growth factors of human dermal fibroblasts in a quiescent state owing to cell-matrix contact inhibition, Matrix, 11, pp. 71-75, (1991)
  • [4] Read, What happened to urogastrone?, Q J Med, 62, pp. 1-6, (1987)
  • [5] Cohen, Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal., J Biol Chem, 237, pp. 1555-1562, (1962)
  • [6] Cohen, Epidermal growth factor, Biosci Rep, 6, pp. 1017-1028, (1986)
  • [7] Oka, Orth, Human plasma epidermal growth factor/urogastrone is associated with blood platelets, J Clin Invest, 72, pp. 249-259, (1983)
  • [8] Kasselberg, Orth, Gray, Et al., Immunochemical localization of human epidermal growth factor/urogastrone in several human tissues, J Histochem Cytochem, 33, pp. 315-322, (1985)
  • [9] Cohen, Epidermal growth factor, In Vitro Cell Dev Biol, 23, pp. 239-250, (1987)
  • [10] Pesonen, Viinikka, Myllyla, Et al., Characterization of Material With Epidermal Growth Factor Immunoreactivity in Human Serum and Platelets*, The Journal of Clinical Endocrinology & Metabolism, 68, pp. 486-491, (1991)